Pacific Edge Limited is a cancer diagnostic company specialising in the discovery and commercialisation of diagnostic and prognostic tests for the better detection and management of cancer. The company is currently developing and commercialising its range of Cxbladder bladder cancer tests globally through its wholly owned central laboratories in New Zealand and the USA. As it stands Pacific Edge has four proprietary, novel, accurate, molecular diagnostic products in-market providing actionable results for the better detection and management of urothelial cancer. These products have been extensively tested and validated in international multi-center clinical studies.
Title | Date | Type |
---|---|---|
NZ RegCo Share Price Enquiry into Pacific Edge Limited | Tue, Aug 26 2025 09:10 am | S/PRICE |
ASX Appendix 2A | Mon, Aug 25 2025 11:45 am | GENERAL |
Capital Change Notice - issue of shares | Mon, Aug 25 2025 11:38 am | SECISSUE |
SPH Notice - Westpac Banking Corporation | Thu, Aug 21 2025 08:33 am | SHINTR |
D&O Disclosures – Multiple | Mon, Aug 18 2025 01:15 pm | SHINTR |
Notification of Cessation as Independent Director | Mon, Aug 18 2025 11:26 am | GENERAL |
SPH Notice - Masfen Securities Limited (‘MSL’) | Thu, Aug 14 2025 04:49 pm | SHINTR |
SPH Notice - ANZ New Zealand Investments Limited | Wed, Aug 13 2025 04:30 pm | SHINTR |
Capital Change Notice - expiry of options | Wed, Aug 13 2025 04:28 pm | GENERAL |
ASX documents lodged | Wed, Aug 13 2025 04:22 pm | GENERAL |
Date | Name | No. Held | % | Current |
---|---|---|---|---|
17/04/23 | ANZ New Zealand Investments Limited | 58,714,600 | 6.18 | 7.25 |
18/01/23 | Harbour Asset Management Limited an | 127,988,137 | 14.78 | 15.79 |
10/12/21 | Salt Funds Management Limited | 48,114,089 | 6.95 | 5.94 |
30/09/21 | Westpac Banking Corporation | 52,810,384 | 8.14 | 6.70 |
03/12/20 | AMP Capital Investors (New Zealand) | 36,125,581 | 5.16 | 4.98 |
03/12/18 | Jarden Partners Limited. | 83,613,923 | 15.60 | 17.61 |
06/06/18 | BNP Paribas Nominees (NZ) Limited a | 20,612,121 | 5.47 | 4.42 |
05/07/17 | Investment Services Group Limited | 19,015,596 | 5.94 | 4.76 |
05/07/17 | Devon Funds Management Limited | 19,015,596 | 5.94 | 4.76 |
28/06/17 | Harbour Asset Management & Jarden P | 48,540,480 | 11.11 | 12.14 |
17/02/17 | K One W One Limited | 19,786,297 | 5.39 | 4.96 |
07/11/16 | Superlife Trustee Nominees Limited, | 2,033,501 | 5.99 | 0.53 |
Date | Name | No. Held | % | Details | Other |
---|---|---|---|---|---|
21/12/22 | Peter Meintjes | 185,000 | - | - | - |
22/03/22 | Antony George Barclay | 20,000 | - | - | - |
09/12/21 | Bryan Williams | 237,427 | - | - | - |
22/10/21 | David Gregory Darling | 4,611,562 | - | - | - |
22/10/21 | Grant Edward Gibson | 27,456 | - | - | - |
20/10/21 | Sarah Park | 58,591 | - | - | - |
06/10/21 | Chris Gallaher | 602,058 | - | - | - |
16/03/21 | Anna Kate Stove | 5,000 | - | - | - |
19/12/19 | Kate Elizabeth Rankin | 1,775,890 | - | - | - |
16/08/19 | James Miller Suttie | 190,568 | - | - | - |
30/05/19 | John Duncan | 900,333 | - | - | - |
30/06/16 | Christopher John Swann | 1,171,641 | 0.37 | - | - |